236 related articles for article (PubMed ID: 34766373)
1. Immune activity in Merkel cell carcinoma.
Nakamura M; Morita A
J Dermatol; 2022 Jan; 49(1):68-74. PubMed ID: 34766373
[TBL] [Abstract][Full Text] [Related]
2. New perspectives in Merkel cell carcinoma.
Del Marmol V; Lebbé C
Curr Opin Oncol; 2019 Mar; 31(2):72-83. PubMed ID: 30694842
[TBL] [Abstract][Full Text] [Related]
3. Advances in Immunotherapy for Metastatic Merkel Cell Carcinoma: A Clinician's Guide.
Paulson KG; Bhatia S
J Natl Compr Canc Netw; 2018 Jun; 16(6):782-790. PubMed ID: 29891528
[TBL] [Abstract][Full Text] [Related]
4. Current and preclinical treatment options for Merkel cell carcinoma.
Celikdemir B; Houben R; Kervarrec T; Samimi M; Schrama D
Expert Opin Biol Ther; 2023; 23(10):1015-1034. PubMed ID: 37691397
[TBL] [Abstract][Full Text] [Related]
5. Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates.
Becker JC; Stang A; Schrama D; Ugurel S
Am J Clin Dermatol; 2024 Jul; 25(4):541-557. PubMed ID: 38649621
[TBL] [Abstract][Full Text] [Related]
6. Merkel Cell Carcinoma Therapeutic Update.
Cassler NM; Merrill D; Bichakjian CK; Brownell I
Curr Treat Options Oncol; 2016 Jul; 17(7):36. PubMed ID: 27262710
[TBL] [Abstract][Full Text] [Related]
7. Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer.
Bhatia S; Afanasiev O; Nghiem P
Curr Oncol Rep; 2011 Dec; 13(6):488-97. PubMed ID: 21953511
[TBL] [Abstract][Full Text] [Related]
8. Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma.
Garcia-Carbonero R; Marquez-Rodas I; de la Cruz-Merino L; Martinez-Trufero J; Cabrera MA; Piulats JM; Capdevila J; Grande E; Martin-Algarra S; Berrocal A
Oncologist; 2019 Oct; 24(10):1375-1383. PubMed ID: 30962295
[TBL] [Abstract][Full Text] [Related]
9. Current concepts and approaches to merkel cell carcinoma.
Babadzhanov M; Doudican N; Wilken R; Stevenson M; Pavlick A; Carucci J
Arch Dermatol Res; 2021 Apr; 313(3):129-138. PubMed ID: 32666149
[TBL] [Abstract][Full Text] [Related]
10. Updates on the diagnosis, current and future therapeutic options in Merkel-cell carcinoma.
Turshudzhyan A; Hadfield M; Grant-Kels J
Melanoma Res; 2021 Oct; 31(5):421-425. PubMed ID: 34284460
[TBL] [Abstract][Full Text] [Related]
11. Immune Checkpoint Inhibitors and Beyond: An Overview of Immune-Based Therapies in Merkel Cell Carcinoma.
Samimi M
Am J Clin Dermatol; 2019 Jun; 20(3):391-407. PubMed ID: 30784027
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for Merkel cell carcinoma.
Angeles CV; Sabel MS
J Surg Oncol; 2021 Mar; 123(3):775-781. PubMed ID: 33595894
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for Merkel Cell Carcinoma.
Nagase K; Narisawa Y
Curr Treat Options Oncol; 2018 Sep; 19(11):57. PubMed ID: 30238195
[TBL] [Abstract][Full Text] [Related]
14. The changing paradigm of managing Merkel cell carcinoma in Australia: An expert commentary.
Kok DL; Wang A; Xu W; Chua MST; Guminski A; Veness M; Howle J; Tothill R; Kichendasse G; Poulsen M; Sandhu S; Fogarty G
Asia Pac J Clin Oncol; 2020 Dec; 16(6):312-319. PubMed ID: 32757453
[TBL] [Abstract][Full Text] [Related]
15. Glucose-6-phosphate dehydrogenase correlates with tumor immune activity and programmed death ligand-1 expression in Merkel cell carcinoma.
Nakamura M; Nagase K; Yoshimitsu M; Magara T; Nojiri Y; Kato H; Kobayashi T; Teramoto Y; Yasuda M; Wada H; Ozawa T; Umemori Y; Ogata D; Morita A
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33361404
[TBL] [Abstract][Full Text] [Related]
16. Molecular and immune targets for Merkel cell carcinoma therapy and prevention.
Cohen L; Tsai KY
Mol Carcinog; 2019 Sep; 58(9):1602-1611. PubMed ID: 31116890
[TBL] [Abstract][Full Text] [Related]
17. Updates on Merkel Cell Carcinoma.
Emge DA; Cardones AR
Dermatol Clin; 2019 Oct; 37(4):489-503. PubMed ID: 31466589
[TBL] [Abstract][Full Text] [Related]
18. Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell Carcinoma.
Lahman MC; Paulson KG; Nghiem PT; Chapuis AG
J Invest Dermatol; 2021 Aug; 141(8):1897-1905. PubMed ID: 33863500
[TBL] [Abstract][Full Text] [Related]
19. [Immune checkpoint inhibition in Merkel cell carcinoma].
Terheyden P; Mohr A; Langan EA
Hautarzt; 2019 Sep; 70(9):684-690. PubMed ID: 31468071
[TBL] [Abstract][Full Text] [Related]
20. Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.
Vandeven N; Nghiem P
Immunotherapy; 2016 Jul; 8(8):907-21. PubMed ID: 27381685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]